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Abstract
Introduction: Stiff limb syndrome is a clinical feature of the stiff person syndrome, which is a rare and disabling
neurologic disorder characterized by muscle rigidity and episodic spasms that involve axial and limb musculature.
It is an autoimmune disorder resulting in a malfunction of aminobutyric acid mediated inhibitory networks in the
central nervous system. We describe a patient diagnosed by neurological symptoms of stiff limb syndrome with a
good outcome after treatment, and a review of the related literature.
Case presentation: A 49-year-old male patient presented with a progressive stiffness and painful spasms of his
both legs resulting in a difficulty of standing up and walking. The diagnosis of stiff limb syndrome was supported
by the dramatically positive response to treatment using diazepam 25 mg/day and baclofen 30 mg/day.
Conclusion: This clinical case highlights the importance of a therapeutic test to confirm the diagnosis of stiff limb
syndrome especially when there is a high clinical suspicion with unremarkable electromyography
Introduction
Stiff person syndrome (SPS) is characterized by axial
rigidity, progressive stiffness, and spontaneous, reflex- or
actioninduced painful spasms of the paraspinal, abdom-
inal and occasionally proximal leg muscles associated
with a lumbar hyperlordosis [1]. Electrophysiological
findings are typically continous motor unit activity with
abnormal exteroceptive reflexes, but a normal interfer-
ence pattern during spasms [2].
Most patients have antiglutamic acid decarbolxylase
(GAD) antibodies in both serum and cerebral spinal
fluid (CSF) with additional evidence of autoimmune dis-
ease. During the last few years, several cases with SPS
were reported whose symptoms were confined to one
lower limb [3]. the condition was named as the “stiff
leg” or “stiff limb” syndrome (SLS). We describe a
patient with signs and symptoms closely resembling
those seen in cases of SLS.
Case presentation
A 49-year-old man from a North African origin and
with a Moroccan nationality presented with a 2-year his-
tory of progressive stiffness and painful spasms of his
both legs, with recent worsening of his condition over
the last few weeks resulting in a considerable difficulty
of standing up and walking. There was no past history
of diabetes, or other auto-immune diseases. The family
history was unremarkable. On admission, the lower
limbs were rigid with a flexum of the hips and knees,
movements were severely limited and painful, and
strength could not be assessed because of rigidity and
spasms. A slightly increased tone was noted in his upper
limbs, with normal muscular strength and without any
movement limitation. No paraspinal or axial contrac-
tions were palpated. Sensory examination was normal
except for reduced vibration sense in both lower extre-
mities. Deep tendon reflexes were normal in upper
limbs. Patellar and Achilles jerks could be elicited mark-
edly. Plantar response was flexor bilaterally. Functionally
the patient was unable to walk because of the rigidity in
his both legs. He had an intact intellect and there were
no other neurologic abnormalities.
Results of routine laboratory tests including full blood
count (FBC), serum electrolytes, blood urea nitrogen,
creatinine, glucose and liver enzymes were normal. The
erythrocyte sedimentation rate (ESR) and C-reactive
protein (CRP) values were normal. Chest X-rays and
abdominal ultrasonography revealed no abnormalities.
Magnetic resonance imaging of the whole neuraxis and
EEG were also normal. Cerebrospinal fluid examination
was unremarkable, there were no atypical cells found on
cytopathological analysis. Electromyography of the lower
limbs revealed no abnormalities. Serologic testing for
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HIV, syphilis, viral hepatitis B and C was negative. Anti-
mitochondrial antibodies and anti-cytoplasm antibodies
were found in the serum, while antinuclear antibodies
(ANA) and anti- DNA screening and auto-antibodies to
glutamic acid decarboxylase (GAD) were within normal
limits. Anti-amphiphysin antibodies test wasn’t carried
out. With the high suspicion that the clinical case could
be a SLS, oral diazepam was administered in high doses
(25 mg/day) after which we observed a dramatic remis-
sion of the clinical state with marked reduction of the
hypertonus and the patient could walk with little aid.
The administration of 30 mg of baclofen daily provided
relief of symptoms.
Discussion
Our patient’s symptoms had an insidious onset and
chronic progressive course. The stiffness and painful
spasms were quite confined to the lower limbs, the axial
muscles being spared. Spasms induced by movement or
other stimuli were an important cause of disability.
Brainstem and pyramidal sings were absent and muscle
strength seemed to be normal except when interrupted
by spasms or hampered by severe rigidity. Extensive
diagnostic work-up including imaging of the whole
neuraxis and search for evidence of an infectious, malig-
nant, or inflammatory cause did not reveal another
etiology. Other potential causes of similar symptoms
such as neuromyotonia were also ruled out by neuroi-
maging and electrophysiological studies. Even if Immu-
nocytochemistry studies failed to demonstrate anti-GAD
auto-antibodies, our patient’s history, clinical examina-
tion findings, and response to benzodiazepines were all
very suggestive of SLS.
“SLS” is a variant of “stiff person syndrome” (SPS)
which is a rare auto-immune neurological condition first
described in 1956 by Moersch and Woltman [2]. It is
characterized by progressive muscular rigidity and pain-
ful spasm.
SPS remains a clinical diagnosis with the following cri-
teria: [1] A prodrome of episodic aching stiffness of axial
muscles [2]. Progression to include stiffness of proximal
limbs [3]. Painful spasms elicited by triggers [4].
Increased lumbar lordosis (5) Normal sensation, motor
function and intellect. (6) Electromyographic findings
typical of continuous motor activity that can be abol-
ished by diazepam administration [3].
Abnormal cutaneomuscular reflexes argue against the
diagnosis of SLS and should prompt the search for
another cause [4].
The cause of stiff-person syndrome is unknown but an
auto-immune pathogenesis is suspected because of the
presence of antibodies against glutamic acid decaroxy-
lase (GAD), the rate-limiting enzyme for synthesis of
the inhibitory neurotransmitter gamma-aminobutyric
acid (GABA) [1,5], and the association with other auto-
immune diseases such as diabetes and thyroiditis [6].
The loss of GABAergic input into motor neurons is
thought to produce the tonic firing of motor neurons at
rest and lead to their excessive excitation in response to
sensory stimulation [1]. Patients with SPS have high tit-
ter GAD-antibodies which are synthesized intra thecally
and seem to impair the in situ synthesis of GABA [6].
SLS is a newly emerging entity considered as a focal
form of SPS in which the symptoms are confined to a
distal limb (usually the leg), although sometimes this
progresses to involve the axial musculature as well [4].
In this group of patients, sphincter disturbance may
develop years after the onset; abnormally segmented
electromyographic (EMG) activity is recorded during
spasms in addition to the electrophysiological findings
of SPS; anti-GAD antibodies and autoimmune diseases
are less common, [7] as in our case. The standard ther-
apy for patients has been the GABA neuromodulator
diazepam. Initial results are usually good, which was the
case of our patient, but adaptation and disease progres-
sion make increased dose up to 200 mg daily necessary.
The subsequent side effects as well as the risk of addic-
tion limit the applicability of high-dose oral therapy [7].
Improvement of SPS symptoms with immunotherapy
provides additional strong support for the auto-immune
hypothesis of the disease. Plasmapheresis has had vari-
able effect [8]. Intravenous immunoglobulin therapy has
been more successful [9]. Physical therapy can substan-
tially improve quality of life [10].
Consent
Written informed consent was obtained from the patient
for open access publication of this case report.
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